Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — August 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • L Offline
    L Offline
    lahn1
    wrote on sidst redigeret af
    #97

    Tak til jer begge, og interessant side der Bulder 🙂

    1 Reply Last reply
    0
    • K Offline
      K Offline
      kkjoel
      wrote on sidst redigeret af
      #98

      Ja.meget interessant skriv. Tak for linket, Bulder 🙂

      1 Reply Last reply
      0
      • K Offline
        K Offline
        kkjoel
        wrote on sidst redigeret af
        #99

        Og en del andre - måske interessante - artikler på det site. Men lader ikke til vedkommende har sk
        revet noget siden 6.1.2020...

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #100

          God morgen. 🙂

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #101

            Medwatch om Tepezza

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #102

              Link Preview Image
              Aflagt Genmab-middel sælger stort – milliarder kan være på vej i royalties

              Det tidligere Genmab-middel Tepezza sælger langt bedre, end hvad den nuværende ejer Horizon Therapeutics turde håbe på. Da Genmab har ret til royalties, kan der være milliarder på vej til det danske biotekfirma.

              favicon

              (medwatch.dk)

              1 Reply Last reply
              0
              • T Offline
                T Offline
                transalp
                wrote on sidst redigeret af
                #103

                Go morgen.. 🙂

                1 Reply Last reply
                0
                • M Offline
                  M Offline
                  Mogan
                  wrote on sidst redigeret af
                  #104

                  God morgen 🙂

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #105

                    Trump igen igen: https://www.proinvestor.com/investornyt/664577/trump-fortsaetter-pres-pa-europaeiske-healthcarenu-med-kob-usa-medicin

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #106

                      Nu har han hamstret covid-19 medicin og omdirigeret fly med mundbind - manden er forhåbentlig ude næste år.

                      1 Reply Last reply
                      0
                      • B Offline
                        B Offline
                        Bella1
                        wrote on sidst redigeret af
                        #107

                        I så fald venter det totale kaos...

                        1 Reply Last reply
                        0
                        • M Offline
                          M Offline
                          Mcjean
                          wrote on sidst redigeret af
                          #108

                          Hmmm synes essensen i denne historie og de tiltag han laver virker yderst fornuftige, overskriften kan måske forvirre lidt og virker faktisk direkte latterlig og misvisende.

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            Bella1
                            wrote on sidst redigeret af
                            #109
                            • når overskrifter forfattes af fjenden...
                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #110

                              Det er vi så ikke enige i 😉

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                Mcjean
                                wrote on sidst redigeret af
                                #111

                                Virker nærmest som ren manipulation.......og så sætter man Novo's flag ind i artiklen, det burde politianmeldes......har de shortet NOVO, dette har intet med NOVO at gøre.

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #112

                                  Janssens first DuoBody that did not make it - old stuff for hardcore fans:

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Sukkeralf
                                    wrote on sidst redigeret af
                                    #113

                                    Link Preview Image
                                    Characterization of concurrent target suppression by JNJ-61178104, a bispecific antibody against human tumor necrosis factor and interleukin-17A - PubMed

                                    Tumor necrosis factor (TNF) and interleukin (IL)-17A are pleiotropic cytokines implicated in the pathogenesis of several autoimmune diseases including rheumatoid arthritis (RA) and psoriatic arthritis (PsA). JNJ-61178104 is a novel human anti-TNF and anti-IL-17A monovalent, bispecific antibody that …

                                    favicon

                                    PubMed (pubmed.ncbi.nlm.nih.gov)

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Sukkeralf
                                      wrote on sidst redigeret af
                                      #114

                                      JNJ-61178104 was shown to engage its targets, TNF and IL-17A, in systemic circulation measured as drug/target complex formation in normal cynomolgus monkeys (cyno). Surprisingly, quantitative target engagement assessment suggested lower apparent in vivo target-binding affinities for JNJ-61178104 compared to its bivalent parental antibodies, despite their similar in vitro target-binding affinities.

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #115

                                        The target engagement profiles of JNJ-61178104 in humans were in general agreement with the predicted profiles based on cyno data, suggesting similar differences in the apparent in vivo target-binding affinities. These findings show that in vivo target engagement of monovalent bispecific antibody does not necessarily recapitulate that of the molar-equivalent dose of its bivalent parental antibody

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #116

                                          Our results also offer valuable insights into the understanding of the pharmacokinetics/pharmacodynamics and target engagement of other bispecific biologics against dimeric and/or trimeric soluble targets in vivo.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger